Compound Detail
CHEMBL74355
VOLINANSERIN 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL74355 |
| Name | VOLINANSERIN |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | HXTGXYRHXAGCFP-OAQYLSRUSA-N |
15
Targets
44
Activities
3
Assay Types
6
PK Parameters
20
Publications
8
Known Names
2
Indications
1
Mechanisms
Molecular Properties
373.5
MW (Da)
3.83
ALogP
4
HBA
1
HBD
41.9
PSA (Ų)
0.80
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serotonin 2a (5-HT2a) receptor antagonist | ANTAGONIST | 5-hydroxytryptamine receptor 2A | ✓ | ✓ |
Indications
Sleep Wake Disorders Depressive Disorder
Activity Summary
Ki 41 meas. best 10.0
IC50 2 meas. best 8.32
Kd 1 meas. best 9.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 2A CHEMBL322 | Ki | 10.0 | 9.2957 | 0.1 | 7 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 10.0 | 9.4056 | 0.1 | 9 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Kd | 9.85 | 9.85 | 0.1 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 8.32 | 8.32 | 4.8 | 2 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 7.89 | 7.3467 | 13.0 | 6 |
| Kappa-type opioid receptor CHEMBL237 | Ki | 6.99 | 6.99 | 102.7 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.89 | 6.89 | 128.0 | 1 |
| Histamine H1 receptor CHEMBL231 | Ki | 6.88 | 6.44 | 132.5 | 2 |
| Sigma intracellular receptor 2 CHEMBL4105907 | Ki | 6.69 | 6.69 | 205.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 6.38 | 6.38 | 420.0 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 6.07 | 6.07 | 859.3 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 CHEMBL1866 | Ki | 5.97 | 5.97 | 1060.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | Ki | 5.96 | 5.96 | 1100.0 | 4 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 5.9 | 5.9 | 1258.9 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 5.89 | 5.83 | 1300.0 | 4 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 5.89 | 5.89 | 1288.5 | 1 |
| Alpha-1B adrenergic receptor CHEMBL232 | Ki | 5.42 | 5.42 | 3807.6 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 8.0 | ng.hr.mL-1 | - |
| Cmax | 5.355 | nM | - |
| F | 3.0 | % | Eutheria |
| MRT | 1.0 | hr | - |
| T1/2 | 6.6 | hr | Homo sapiens |
| Vd | 4.6 | L.kg-1 | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | HEK-293T | 10 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 8 |
| - | 10.6019/CHEMBL4689842 | U2OS | 7 |
| 11784153 | 10.1021/jm011030v | ADMET | 6 |
| 29555153 | 10.1016/j.bmcl.2018.02.058 | 5-hydroxytryptamine receptor 2A | 4 |
| 33887904 | 10.1021/acs.jmedchem.1c00484 | Unchecked | 4 |
| 19329329 | 10.1016/j.bmc.2009.03.021 | 5-hydroxytryptamine receptor 2A | 3 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 2 |
| 19329329 | 10.1016/j.bmc.2009.03.021 | No relevant target | 2 |
| 18187324 | 10.1016/j.bmcl.2007.12.054 | 5-hydroxytryptamine receptor 2A | 2 |
| - | 10.6019/CHEMBL3301361 | ADMET | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 2 |
| 15993598 | 10.1016/j.bmcl.2005.05.104 | 5-hydroxytryptamine receptor 2A | 2 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 11170639 | 10.1021/jm0002432 | 5-hydroxytryptamine receptor 2A | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 2 |
| 11784153 | 10.1021/jm011030v | 5-hydroxytryptamine receptor 2A | 2 |
Data from ChEMBL 36 via Core Engine